Maximizing Commercial Outcomes for Oncology Medicines

We see what’s possible and bring it to market

Recent News & Events

View All
Secura Bio Announces Journal of Clinical Oncology Publication of Final Results of Duvelisib PRIMO Phase 2 Trial in Relapsed/Refractory Peripheral T-cell Lymphoma Apr 27, 2026 Press Release
Secura Bio Expands Chief Financial Officer Will Brown’s Leadership Role to Include Chief Operating Officer Feb 11, 2026 Press Release
Back to top